INTRODUCTION
The initiation of transcription by RNA polymerase II (Pol II) in TATA box containing promoters is currently thought to be dependent on the efficiency of binding of the TF HD complex to the promoter. The binding of TF IID at the promoter initiates a sequential interaction of the basic transcription factors TF IIA, B, E, F, G, H and RNA Pol II with the template to form the initiation complex (for review see ref. 1) .
Although initially discovered as a large, multi-component complex (>700 kDa; 2,3) that would bind at the TATA element at -30 ofmany class II genes, TF IID is now known to be involved in transcription from promoters that lack a canonical TATA box (4, 5) . In this latter situation, other factors binding at the promoter are envisaged to act, at least in part, in a 'tethering' capacity helping to anchor TF IID to the template. From the study of such class II promoters, a second element involved in initiation of transcription was discovered, namely, the 'initiator' (Inr) which is usually located over the transcriptional start or cap site (6) . In addition to the TATA box, different Inr elements have been identified for different promoters (7) .
The TATA binding protein (TBP) component of TF IID has been cloned and characterized from many different species (8) and has since been shown to be a 'core' component of the initiation complex of Pol I and Pol Ill promoters where it forms part of the SLI and TF IIIB/SNAPc factors, respectively (9, 10 and refs therein). A different set of TBP associated factors (TAFs) , allows it to function as a nucleation centre for the basic transcriptional machinery on the promoters of all classes of genes (11) . TAFs which mediate both activation and repression of transcription have been described (12, 13) .
Studies in vitro suggest that the rate of association of TF IID with the promoter is slow and therefore thought to be rate limiting in the formation of the pre-initiation complex (14, 15) . However, it is not clear that this is the case in vivo. Transient transfection assays have suggested that TF ID may be rate limiting on TATA-containing but not TATA-lacking promoters (16) . The main problem associated with such studies is that they do not study the initiation of transcription at the same level as normally occurs in vivo in a natural chromatin environment and in the context ofall the regulatory sequences for a given gene. However, the discovery of the key regulatory elements in the human P-globin gene locus has made such an analysis possible.
The high level erytbroid and developmental stage-specific expression of the ,-like globin genes is under the primary control of the locus control region (LCR) which is located 5' of the entire gene cluster. The ,B-globin LCR consists of five developmentally stable, erythroid-specific regions of DNaseI hypersensitivity (17) (18) (19) ; Raguz and Grosveld, in preparation) and is defined by its ability to confer physiological levels of expression of the globin genes independent ofthe position ofintegration in the host genome of transgenic mice (17) and stable transfected erythroid tissue culture cells (20, 21) .
In earlier studies we have shown that the PLCR can fully activate transcription from a minimal (-globin promoter consisting of a TATA box (-30) , CCAAT (-75) and CACC (-90) elements (22 (23, 24) and for the adult chicken ,-globin gene, the TATA box region also binds the erythroid factor GATA-1 (25) .
Because of these results and to gain further insight into the molecular mechanisms of LCR/promoter interactions, we undertook a study to 
MATERIALS AND METHODS

DNA constructs
As before, the hybrid human ,B-globin/mouse H2K gene (22) Electrophoretic mobility shift assay analysis was carried out using total nuclear protein extracts from HeLa, K562 and MEL cells as described previously (27) . Bacterially expressed TBP was provided by Steve Jackson (Cambridge, UK) and the TBP EMSAs were quantitated by phosphorimage analysis, using a Molecular Dynamics phosphorimager (Fig. 3) . Methylation interference
Expression studies
The maintenance, transfection by electroporation and selection of stable transfected pools of MEL cells was exactly as previously described using 50 jg linearised plasmid DNA and 3 x 107 cells per sample (28) . Murine fibroblast L-cells were grown in DMEM containing 10% (v/v) foetal calf serum. L-cells were transfected with Lipofectin (Gibco-BRL) according to the manufacturer's instructions, using 20 ,ug linearised plasmid DNA, 100 ,ug lipofectin and 3 x 106 cells seeded on a 10 cm diameter Petri dish. Stable transfected clones were selected in 500 ,ug/ml G418 (Gibco-BRL) and were obtained at a frequency of -I in 104.
The preparation of RNA and analysis by S 1-nuclease protection assays were carried out as before using 5' end-labelled DNA probes (22, 28) .
In the case of the various mutations, homologous probes were isolated for the analysis in order to measure give a 85 nt SI-nuclease protected product (22) . A 700 bp HindIII-NcoI fragment from the 5' halfof the mouse [-maj globin gene was used which gives a 96 nt S 1-protected product from the 5' portion of the second exon of the mRNA (27) . The ,3-actin probe was a 320 bp BamHI-Aval fragment from a human ,3-actin cDNA clone (29) which gives a 100 nt S 1-protected product from the homologous murine mRNA (30) . The products were resolved on a 6% polyacrylamide gel in the presence of 8 M urea.
RESULTS
TATA box and Cap site binding factors
Initial in vitro DNaseI footprint experiments on the human 3-globin promoter using total nuclear extracts from erythroid (murine erythroleukaemia, K562) and non-erythroid (HeLa) cells, revealed an extended area of protection from the TATA box to past the site of initiation of transcription (data not shown). To gain insight into the factors binding over this region, EMSA were employed using the same nuclear extracts and two overlapping oligonucleotides from -34 to -I (TATA) and from -22 to +9 (Cap; Fig. 1 , Table 1 ). Both probes showed several retarded bands, indicating that multiple proteins could potentially bind over the TATA box (T1, T2 and T3) and cap site regions (C1, C2A, C2B and C3). The bands between T2 and T3 or C2 and C3 as well as those below T3, are non-specific as they do not self-compete. One of these factors (T2/C2B) was detected only with the erythroid extracts and was bound by both the TATA and Cap probes. Another factor (T3/C3) that was not erythroid-specific, also seemed to bind to both TATA and Cap oligonucleotides. A slow migrating species was seen with both probes (TI and C1). However, this did not appear to be the same protein, as it was not cross competable by the two probes used ( Fig. 2A) . Sequence comparison, migration characteristics and competition experiments provided identification of most of these factors ( Fig. 2A) and the results are summarized in Table 2 (upper panel). The factor T2/C2B is GATA-1 as it was competed efficiently by a probe corresponding to the -200 GATA-I binding site from the human ,B-globin promoter (27; Fig. 2A , lanes GATA) and could be supershifted with GATA-I antibodies (31; data not shown). The residual binding activity with the Cap probe after GATA experiments were carried out as described previously (27) .
competition is the weakly binding factor C2A ( Fig. 1 a slightly slower mobility than GATA-1 and is not affected by GATA-1 antibodies (data not shown). The factor designated T3/C3 was competed by an oligonucleotide corresponding to the YYl binding site (32, 33) from the cap region of the adeno-associated virus p5 gene ( Fig. 2A, TF IID binding at the TATA box under the low salt conditions used in all the other EMSA experiments (see below). Information from methylation interference data was used to generate mutations for each of the proteins. These mutants are summarized in Table 1 and we used EMSA to show that the mutations specifically abolish the binding of each of the factors without creating any new activity (Fig. 2B) , mTl for Spl, mT2 and mT2A for GATA-1 and mT3 for YY1. Of these mutants mT3 also showed a reduced binding for the TATA box factor TBP (Fig.  3) although we currently have no explanation for this observation. In addition to mT3, we generated a further set of TATA mutants which show a decreasing capacity to bind TBP (Fig. 3, Table 2 ), namely mT10 and mT7 which bind -4% and <4% respectively, mT5 (13%), mT6 (30%) and mT9 (50%).
The Figure 1 . Table 1 were assessed by EMSAs for their ability to bind recombinant TATA binding protein (TBP). The oligonucleotide probes (0.2 ng) used were the same as those described in Figure 2 . The wild type (Twt) sequence acted as a control. This figure shows the phosphorimage which was used to quantify the data ( Table 2 ). The result with the wild type human f,Bglobin TATA box (Twt) was taken as 100%.
days in the presence of 2% DMSO. Expression of the transfected gene was assessed by an S 1 -nuclease protection assay using end-labelled DNA probes (Fig. 4) .
Functional analysis of TATA box mutants; TBP binding is not rate limiting in transcription initiation Mutants that prevent the binding of SpI (mT1), GATA-1 (mT2) and YY1 (mT3) near the TATA box (Fig. 2B) , still gave full transcriptional activation (Fig. 4A, lanes mTl, mT2 and mT3 ). The only mutants in this region that decreased transcription (Fig.  4B,C) were those which markedly reduced the binding of TBP, namely mT5, mT7 and mTO0 (Fig. 3 ) of which mT5 (-29 A to C) is a natural 0-thalassaemia mutation (37) . Interestingly, three of the mutants that showed a reduced binding for TBP namely mT3, mT6 and mT9 (Fig. 3) , did not result in decreased transcription ( Fig. 4A-C) . Only when the ability to bind TBP is reduced still further (mT5, mT7 and mT1O), does this result in decreased expression (Table 2 ), in agreement with the lower levels of i-globin RNA found in patients with the mT5 mutation (37 Table 1 and Fig. 3 ) and the amount of RNA transcribed from the +1 or downstream positions of the constructs containing these mutations (Fig. 4) Table 1 were built into the ,LCR expression cassette and used to generate stable transfected, G418 resistant pools ofMEL cells (see Materials and Methods). Total RNA was isolated from the large pools of clones that were produced after they had been induced to undergo 4 days of erythroid differentiation in the presence of 2% DMSO. Samples (2 ig) were simultaneously assayed for the f-H2 transgene and the endogenous 3-maj globin sequences by SI-nuclease protection using end-labelled DNA probes which detect the 5' end of the mRNAs. The Sl-nuclease protected fragment for the 1-H2 mRNA is 85 nucleotides and that for ,B-maj 96 nucleotides. Homologous probes for the TATA and cap mutants were employed. Panel D is a longer exposure of panel C and shows the minor bands corresponding to initiation events downstream of the normal Cap site. WT refers to the result obtained with the wild type promoter. mTl-mT10 refer to the TATA box mutants and mCl-mC3 to the cap mutants. The results were quantified by phosphorimage analysis correcting for variation in eryturoid induction levels by using fS-maj globin as an internal standard. The level obtained with the wild type promoter was taken as 100% expression (see Table  2 ). Different specific activity probes were used on different gels. Only a small part of the gels is shown for space reasons.
well with the observed very mild thalassaemia which arises from this mutation in human subjects (38) .
Testing specialized TATA elements
Our observation that GATA-1 binding at the human P-globin TATA box does not appear to be functionally significant, is at variance with the results obtained with this same region from the chicken gene (25) . This could possibly be explained by the fact i-Il2 Figure 5 . Expression analysis of TATA box mutants in murine L-cells. Selected TATA box mutants (see Table 1 ) were stably transfected into mouse fibroblast L-cells by lipofection (see Materials and Methods). Total RNA from the three independent pools ofclones that were generated was then analysed by an SI -nuclease protection assay, as described in Figure 4 . Assays probed for the ,B-H2 sequences (upper panel) contained 20 ig RNA per reaction. Samples (2 gg) were also assayed for IS-actin mRNA as a loading control. The 1-H2 probe gives the same ,B-H2 Sl-protected product as in Figure 4 . The 3-actin probe gives a 100 nucleotide SI-protected product.
RNA from untransfected L-cells (L) and 13-H2 transfected MEL (M) acted as negative and positive controls, respectively.
that GATA-1 binds downstream of the TATA box in the human f-globin promoter rather than at the TATA box as is the case in the chicken ,3-globin promoter. The sequence of the chicken 0-globin TATA box is AGATAAAA, which allows it to bind GATA-1 strongly as opposed to the corresponding human element (ACATAAAA). Since the function of GATA-1 in the chicken f-globin study was assessed by in vitro transcription and transient transfection assays, we decided to test whether its proposed specialized role at the TATA box could be extended to chromatin as part of our LCR based expression system. We therefore built TATA elements within the human j-globin promoter with varying affinities for TF IID and GATA-l (Figs 2B  and 3 and Table 2 ). The TATA box regions of the mouse (mT8), human (wt) and chicken (mT9) ,-globin genes have a different affinity for TBP (Fig. 3) , which are 150, 100 and 50%, respectively, (Table 1 ) using the human sequence as the standard. In contrast, the chicken sequence has a much higher affmity for GATA-1 as expected (Fig. 2B , Table 2 ). In addition, we built a mutant TATA element, mTl0 (AGATAGCC), which binds GATA-1 (Fig. 2B, lane T10) as strongly as the chicken element, but which has minimal binding ofTBP (Fig. 3) . The severe TATA mutant mT7, acted as a control which does not bind TBP (Fig. 3 , Table 2 ), but which retained GATA-1 binding at -12 like the other constructs in this series (Fig. 2B) . Expression ofthese mutants in MEL cells revealed that the wild type human P-globin TATA box (Fig. 4C , lane WT, Table 2 ), directed initiation of transcription with equal efficiency as that from the mouse (Fig. 4C, lanes mT8) or chicken (Fig. 4C , lanes mT9) genes. Thus, the higher affinity for GATA-1, seen with the chicken TATA box does not result in any physiological effect. The only difference that could be discerned between the mouse or human and chicken elements was the appearance of aberrant transcripts initiated downstream of the natural cap site (Fig. 4D) . Some of these appear to be GATA-1 stimulated transcripts and some were the result of weak TF IID binding as shown by the different starts in mT7 and mT0 (Fig. 4D) . The mTl0 mutant has the same GATA-I binding capacity as the chicken TATA box (mT9), but very low affinity for TBP (Fig. 3 , Table 2 ). Interestingly, the mTlO (GATA-1) promoter produced 2-fold more correctly initiated transcripts than the severe TATA mutant mT7 (Fig. 4C , Table 2 ). In order to confirm that this difference was due to the observed higher affinity for TBP by mT1O than that by mT7 ( Fig.  3 Finally, relatively high levels of correctly initiated transcripts observed with the TATA box mutants mT7 (14%) and mTlO (28%) (Fig. 4C,D (22) . In this study we investigated factors binding over the TATA box and Cap site regions.
Protein-DNA binding studies in vitro using nuclear extracts from erythroid (MEL, K562) and non-erythroid (HeLa) cells
showed that in addition to TBP, three other factors were found to bind around the TATA box of the human 0-globin gene ( Table 2 ).
These were the erythroid factor GATA-1, the ubiquitous transcription factor Spi, a transcriptional activator (39) Fig. 4A and B ; Table 2 ), indicating that these proteins have no significant role at the TATA box in vivo.
The various TATA box mutants tested in this study allowed us to address the question of TBP binding efficiency in regulating initiation of transcription. Electrophoretic mobility shift assays with recombinant TBP (Fig. 3) , indicated the following order of binding efficiency for this factor by the TATA elements tested: mouse (mT8), 150%; human (wt), 100%; chicken (mT9) and mT3, 50%; mT6, 30%; mT5, 13%; mT1O, 4%; mT7, <4% using human (wt) as a 100% reference. Despite the fact that the binding of TBP to the mT9, mT3 and mT6 mutants (Table 2) is between 50 and 30% of the normal human sequence, equal rates of transcription initiation are observed in vivo ( Fig. 4A and B) . Again, in the case ofthe T5 (-28 A to C) mutant which binds TBP at 13% of wild type, transcription is still 30% compared to wild type. Interestingly, the mT5 level of transcription is in agreement with that observed in the 0-thalassaemia patients which carry this mutation (37) , emphasizing that our model system mimics the in vivo situation. However, it is known that TF IID partially purified from HeLa cells produces a DNaseI footprint over the adenovirus major late (AdML) promoter which extends from the TATA box to past the cap site (2, 40) . This is in marked contrast to recombinant TBP which only footprints the TATA box element (41) (42) (43) . The extended footprint given by TF UD is now known to be due to the TAF]g150 component of this complex (44 (36) .
The TATA box mutants mT7 and mTlO have only a weak TBP binding activity (Fig. 3) which is much lower than the inherent TBP binding capacity at the -30 region of some native TATA-less promoters (45) . However, these two mutants still gave significant levels of correctly initiated transcripts ( Fig. 4C; Table 2 ). This may be due to number of different reasons. First, since TAF1I 150 can bind to DNA independently of TBP (44) , this may reflect the residual in vivo binding capacity of TF IID to these TATA box mutants due to this TAF component of the complex. However, this is unlikely to completely account for the observed levels of expression given that TATA box mutants of the Ad2 E1B gene are unable to compete the binding of a purified HeLa cell TF IID fraction to the wild type element (5) . This indicates that the binding of TAFII150 to DNA is weak compared to the TF IID complex as a whole. Alternatively, the binding of TF IID to the mT7 and mT10 mutants may be mediated by an Inr function or by factors associated with upstream promoter elements such as the -200 GATA-1, -85 CACC or -75 CCAAT regions which could position TBP as part ofTF UD at the natural TATA position through some tethering capacity, either by interacting directly with TF IID or through an intermediary, co-activator protein or TAF (46) . However, the observation that most of the transcripts have aberrant downstream start sites (Fig. 4D) would indicate that the 'tethering' capacity of these upstream factors is generally a loose one, resulting in the positioning ofTF UD and subsequently the initiation complex as a whole, over an extended region rather than a single site. This resembles the situation for transcripts from many TATA-less promoters which usually have a cluster of start sites and no demonstrated Ir function.
